The global market for Antibiotic API was valued at US$ 5298 million in the year 2024 and is projected to reach a revised size of US$ 4841 million by 2031, growing at a CAGR of -1.3% during the forecast period.
Antibiotics refer to a class of secondary metabolites with anti-pathogen or other activities produced by bacteria, fungi and other microorganisms or higher animals and plants during their lives. They are chemical substances that can interfere with the development of other living cells. Commonly used clinical antibiotics include extracts from microbial cultures and chemically synthesized or semi-synthetic compounds. This report only counts antibiotic raw materials, excluding various intermediates and penicillin industrial salts.
Global core Antibiotic API manufacturers include UNITED LABORATORIES, RUIYING PIONEER PHARMACEUTICAL, RUIYING PIONEER PHARMACEUTICAL etc. The top 5 companies hold a share about 25%.Asia-Pacific is the largest market, with a share about 60%, followed by Europe and North America with the share about 18% and 8%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibiotic API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic API.
The Antibiotic API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibiotic API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibiotic API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL
Segment by Type
Penicillins
Cephalosporins
Aminoglycosides
Tetracyclines
Quinolones
Macrolides
Lincomycins
Others
Segment by Application
Oral Medicine
Injection Medicine
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibiotic API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibiotic API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Antibiotic API Market Overview
1.1 Product Definition
1.2 Antibiotic API by Type
1.2.1 Global Antibiotic API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Penicillins
1.2.3 Cephalosporins
1.2.4 Aminoglycosides
1.2.5 Tetracyclines
1.2.6 Quinolones
1.2.7 Macrolides
1.2.8 Lincomycins
1.2.9 Others
1.3 Antibiotic API by Application
1.3.1 Global Antibiotic API Market Value by Application (2024 VS 2031)
1.3.2 Oral Medicine
1.3.3 Injection Medicine
1.4 Global Antibiotic API Market Size Estimates and Forecasts
1.4.1 Global Antibiotic API Revenue 2020-2031
1.4.2 Global Antibiotic API Sales 2020-2031
1.4.3 Global Antibiotic API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antibiotic API Market Competition by Manufacturers
2.1 Global Antibiotic API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antibiotic API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antibiotic API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antibiotic API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antibiotic API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antibiotic API, Product Type & Application
2.7 Global Key Manufacturers of Antibiotic API, Date of Enter into This Industry
2.8 Global Antibiotic API Market Competitive Situation and Trends
2.8.1 Global Antibiotic API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antibiotic API Players Market Share by Revenue
2.8.3 Global Antibiotic API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antibiotic API Market Scenario by Region
3.1 Global Antibiotic API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antibiotic API Sales by Region: 2020-2031
3.2.1 Global Antibiotic API Sales by Region: 2020-2025
3.2.2 Global Antibiotic API Sales by Region: 2026-2031
3.3 Global Antibiotic API Revenue by Region: 2020-2031
3.3.1 Global Antibiotic API Revenue by Region: 2020-2025
3.3.2 Global Antibiotic API Revenue by Region: 2026-2031
3.4 North America Antibiotic API Market Facts & Figures by Country
3.4.1 North America Antibiotic API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antibiotic API Sales by Country (2020-2031)
3.4.3 North America Antibiotic API Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antibiotic API Market Facts & Figures by Country
3.5.1 Europe Antibiotic API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antibiotic API Sales by Country (2020-2031)
3.5.3 Europe Antibiotic API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antibiotic API Market Facts & Figures by Region
3.6.1 Asia Pacific Antibiotic API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antibiotic API Sales by Region (2020-2031)
3.6.3 Asia Pacific Antibiotic API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antibiotic API Market Facts & Figures by Country
3.7.1 Latin America Antibiotic API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antibiotic API Sales by Country (2020-2031)
3.7.3 Latin America Antibiotic API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antibiotic API Market Facts & Figures by Country
3.8.1 Middle East and Africa Antibiotic API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antibiotic API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antibiotic API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antibiotic API Sales by Type (2020-2031)
4.1.1 Global Antibiotic API Sales by Type (2020-2025)
4.1.2 Global Antibiotic API Sales by Type (2026-2031)
4.1.3 Global Antibiotic API Sales Market Share by Type (2020-2031)
4.2 Global Antibiotic API Revenue by Type (2020-2031)
4.2.1 Global Antibiotic API Revenue by Type (2020-2025)
4.2.2 Global Antibiotic API Revenue by Type (2026-2031)
4.2.3 Global Antibiotic API Revenue Market Share by Type (2020-2031)
4.3 Global Antibiotic API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antibiotic API Sales by Application (2020-2031)
5.1.1 Global Antibiotic API Sales by Application (2020-2025)
5.1.2 Global Antibiotic API Sales by Application (2026-2031)
5.1.3 Global Antibiotic API Sales Market Share by Application (2020-2031)
5.2 Global Antibiotic API Revenue by Application (2020-2031)
5.2.1 Global Antibiotic API Revenue by Application (2020-2025)
5.2.2 Global Antibiotic API Revenue by Application (2026-2031)
5.2.3 Global Antibiotic API Revenue Market Share by Application (2020-2031)
5.3 Global Antibiotic API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 UNITED LABORATORIES
6.1.1 UNITED LABORATORIES Company Information
6.1.2 UNITED LABORATORIES Description and Business Overview
6.1.3 UNITED LABORATORIES Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 UNITED LABORATORIES Antibiotic API Product Portfolio
6.1.5 UNITED LABORATORIES Recent Developments/Updates
6.2 North China Pharmaceutical
6.2.1 North China Pharmaceutical Company Information
6.2.2 North China Pharmaceutical Description and Business Overview
6.2.3 North China Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 North China Pharmaceutical Antibiotic API Product Portfolio
6.2.5 North China Pharmaceutical Recent Developments/Updates
6.3 RUIYING PIONEER PHARMACEUTICAL
6.3.1 RUIYING PIONEER PHARMACEUTICAL Company Information
6.3.2 RUIYING PIONEER PHARMACEUTICAL Description and Business Overview
6.3.3 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Portfolio
6.3.5 RUIYING PIONEER PHARMACEUTICAL Recent Developments/Updates
6.4 Centrient Pharmaceuticals
6.4.1 Centrient Pharmaceuticals Company Information
6.4.2 Centrient Pharmaceuticals Description and Business Overview
6.4.3 Centrient Pharmaceuticals Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Centrient Pharmaceuticals Antibiotic API Product Portfolio
6.4.5 Centrient Pharmaceuticals Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Company Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aurobindo Pharma Antibiotic API Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Shyndec Pharmaceutical
6.6.1 Shyndec Pharmaceutical Company Information
6.6.2 Shyndec Pharmaceutical Description and Business Overview
6.6.3 Shyndec Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shyndec Pharmaceutical Antibiotic API Product Portfolio
6.6.5 Shyndec Pharmaceutical Recent Developments/Updates
6.7 Nectar Lifesciences
6.7.1 Nectar Lifesciences Company Information
6.7.2 Nectar Lifesciences Description and Business Overview
6.7.3 Nectar Lifesciences Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nectar Lifesciences Antibiotic API Product Portfolio
6.7.5 Nectar Lifesciences Recent Developments/Updates
6.8 Harbin Pharmaceutical Group
6.8.1 Harbin Pharmaceutical Group Company Information
6.8.2 Harbin Pharmaceutical Group Description and Business Overview
6.8.3 Harbin Pharmaceutical Group Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Harbin Pharmaceutical Group Antibiotic API Product Portfolio
6.8.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.9 ACS Dobfar
6.9.1 ACS Dobfar Company Information
6.9.2 ACS Dobfar Description and Business Overview
6.9.3 ACS Dobfar Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ACS Dobfar Antibiotic API Product Portfolio
6.9.5 ACS Dobfar Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Antibiotic API Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 CSPC
6.11.1 CSPC Company Information
6.11.2 CSPC Description and Business Overview
6.11.3 CSPC Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CSPC Antibiotic API Product Portfolio
6.11.5 CSPC Recent Developments/Updates
6.12 QILU ANTIBIOTICS PHARMACEUTICAL
6.12.1 QILU ANTIBIOTICS PHARMACEUTICAL Company Information
6.12.2 QILU ANTIBIOTICS PHARMACEUTICAL Description and Business Overview
6.12.3 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Portfolio
6.12.5 QILU ANTIBIOTICS PHARMACEUTICAL Recent Developments/Updates
6.13 REYOUNG
6.13.1 REYOUNG Company Information
6.13.2 REYOUNG Description and Business Overview
6.13.3 REYOUNG Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.13.4 REYOUNG Antibiotic API Product Portfolio
6.13.5 REYOUNG Recent Developments/Updates
6.14 Orchid Pharma
6.14.1 Orchid Pharma Company Information
6.14.2 Orchid Pharma Description and Business Overview
6.14.3 Orchid Pharma Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Orchid Pharma Antibiotic API Product Portfolio
6.14.5 Orchid Pharma Recent Developments/Updates
6.15 FUAN PHARMACEUTICAL
6.15.1 FUAN PHARMACEUTICAL Company Information
6.15.2 FUAN PHARMACEUTICAL Description and Business Overview
6.15.3 FUAN PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.15.4 FUAN PHARMACEUTICAL Antibiotic API Product Portfolio
6.15.5 FUAN PHARMACEUTICAL Recent Developments/Updates
6.16 Dongying Pharmaceutical
6.16.1 Dongying Pharmaceutical Company Information
6.16.2 Dongying Pharmaceutical Description and Business Overview
6.16.3 Dongying Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Dongying Pharmaceutical Antibiotic API Product Portfolio
6.16.5 Dongying Pharmaceutical Recent Developments/Updates
6.17 FUKANG PHARMACEUTICAL
6.17.1 FUKANG PHARMACEUTICAL Company Information
6.17.2 FUKANG PHARMACEUTICAL Description and Business Overview
6.17.3 FUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.17.4 FUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
6.17.5 FUKANG PHARMACEUTICAL Recent Developments/Updates
6.18 Medya Pharmaceutical
6.18.1 Medya Pharmaceutical Company Information
6.18.2 Medya Pharmaceutical Description and Business Overview
6.18.3 Medya Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Medya Pharmaceutical Antibiotic API Product Portfolio
6.18.5 Medya Pharmaceutical Recent Developments/Updates
6.19 LUKANG PHARMACEUTICAL
6.19.1 LUKANG PHARMACEUTICAL Company Information
6.19.2 LUKANG PHARMACEUTICAL Description and Business Overview
6.19.3 LUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.19.4 LUKANG PHARMACEUTICAL Antibiotic API Product Portfolio
6.19.5 LUKANG PHARMACEUTICAL Recent Developments/Updates
6.20 Dawnrays Pharmaceutical
6.20.1 Dawnrays Pharmaceutical Company Information
6.20.2 Dawnrays Pharmaceutical Description and Business Overview
6.20.3 Dawnrays Pharmaceutical Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Dawnrays Pharmaceutical Antibiotic API Product Portfolio
6.20.5 Dawnrays Pharmaceutical Recent Developments/Updates
6.21 SALUBRIS
6.21.1 SALUBRIS Company Information
6.21.2 SALUBRIS Description and Business Overview
6.21.3 SALUBRIS Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.21.4 SALUBRIS Antibiotic API Product Portfolio
6.21.5 SALUBRIS Recent Developments/Updates
6.22 KELUN
6.22.1 KELUN Company Information
6.22.2 KELUN Description and Business Overview
6.22.3 KELUN Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.22.4 KELUN Antibiotic API Product Portfolio
6.22.5 KELUN Recent Developments/Updates
6.23 HUAFANG PHARMACEUTICAL
6.23.1 HUAFANG PHARMACEUTICAL Company Information
6.23.2 HUAFANG PHARMACEUTICAL Description and Business Overview
6.23.3 HUAFANG PHARMACEUTICAL Antibiotic API Sales, Revenue and Gross Margin (2020-2025)
6.23.4 HUAFANG PHARMACEUTICAL Antibiotic API Product Portfolio
6.23.5 HUAFANG PHARMACEUTICAL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antibiotic API Industry Chain Analysis
7.2 Antibiotic API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antibiotic API Production Mode & Process Analysis
7.4 Antibiotic API Sales and Marketing
7.4.1 Antibiotic API Sales Channels
7.4.2 Antibiotic API Distributors
7.5 Antibiotic API Customer Analysis
8 Antibiotic API Market Dynamics
8.1 Antibiotic API Industry Trends
8.2 Antibiotic API Market Drivers
8.3 Antibiotic API Market Challenges
8.4 Antibiotic API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL
听
听
*If Applicable.